Mendelian randomization analyses suggest a causal role for circulating GIP and IL-1RA levels in homeostatic model assessment-derived measures of β-cell function and insulin sensitivity in Africans without type 2 diabetes (original ) (raw )Immunogenetics of Type 1 Diabetes
Rajni Rani
Autoimmune Disorders - Pathogenetic Aspects, 2011
View PDFchevron_right
Immunological biomarkers for the development and progression of type 1 diabetes
Timothy Tree
Diabetologia
View PDFchevron_right
Evaluation of pro-inflammatory and anti-inflammatory cytokines in type 1 diabetes mellitus
Mie Afify
Bulletin of the National Research Centre
View PDFchevron_right
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge
Jalal Taneera
Nature Genetics, 2010
View PDFchevron_right
The heterogeneous pathogenesis of type 1 diabetes mellitus
Jorma Ilonen
Nature Reviews Endocrinology, 2019
View PDFchevron_right
Characterization of polymorphisms of an interleukin 1 receptor type 1 gene (IL1RI) promotor region (P2) and their relation to Insulin-Dependent Diabetes Mellitus (IDDM)
Jørn Nerup
Cytokine, 1995
View PDFchevron_right
Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis
Bente Pedersen
Journal of Applied Physiology, 2006
View PDFchevron_right
Mendelian Randomization Studies Do Not Support a Causal Role for Reduced Circulating Adiponectin Levels in Insulin Resistance and Type 2 Diabetes
Aurelian Bidulescu
Diabetes, 2013
View PDFchevron_right
Extent of Beta Cell Destruction Is Important but Insufficient to Predict the Onset of Type 1 Diabetes Mellitus
David Klinke
PLoS ONE, 2008
View PDFchevron_right
Ethnic disparities in insulin and glucose-dependent insulinotropic peptide (GIP) responses to intraduodenal glucose in health
Michael Horowitz , Michelle Bound
Acta Diabetologica, 2014
View PDFchevron_right
Multicenter Prevention Trial of Slowly Progressive Type 1 Diabetes with Small Dose of Insulin (the Tokyo Study)
Azuma Kanatsuka
Annals of the New York Academy of Sciences, 2003
View PDFchevron_right
Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes
Isaac Sekitoleko
Diabetologia, 2022
View PDFchevron_right
Associations of β -Cell Function and Insulin Resistance with Youth-Onset Type 2 Diabetes and Prediabetes Among Asian Indians
Amutha Anandakumar
Diabetes Technology & Therapeutics, 2013
View PDFchevron_right
Type 1 diabetes in insulin-treated adult-onset diabetic subjects
Paul Zimmet
Diabetes Research and Clinical Practice, 1998
View PDFchevron_right
Immune State Assessment in People with Diabetes Mellitus
Mohammad J Al-Jassani
The Journal of communicable diseases, 2023
View PDFchevron_right
Random glucose GWAS in 493,036 individuals provides insights into diabetes pathophysiology, complications and treatment stratification
Ben Jones
2021
View PDFchevron_right
Feasibility of genetic and immunological prediction of Type I diabetes in a population-based birth cohort
Jorma Ilonen
Diabetologia, 2001
View PDFchevron_right
A simple way to estimate mean plasma glucose and to identify Type�2 diabetic subjects with poor glycaemic control when a standardized HbA 1c assay is not available
Alpaslan Tuzcu
Diabetic Medicine, 2006
View PDFchevron_right
Serum IL-1ra Is Associated with but Has No Genetic Link to Type 1 Diabetes
Sharad Purohit
Endocrines
View PDFchevron_right
Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance
ANDREA NATALI
Diabetologia, 2003
View PDFchevron_right
Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study
mitra hasheminia
Acta Diabetologica, 2015
View PDFchevron_right
Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis
Antero Kesaniemi
Journal of Clinical …, 2009
View PDFchevron_right
The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes
Matti Uusitupa
PLoS ONE, 2014
View PDFchevron_right
Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities?
Paul Zimmet
Diabetes/Metabolism Research and Reviews, 2010
View PDFchevron_right
The Edinburgh Type 2 Diabetes Study: study protocol
Brian Frier
BMC Endocrine Disorders, 2008
View PDFchevron_right
International Journal of Diabetes and Clinical Research
Myron Szewczuk
View PDFchevron_right
Dynamics of Plasma Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes – Type 1 Diabetes Prediction and Prevention Study (DIPP)
Jorma Ilonen
Scientific Reports, 2018
View PDFchevron_right
Type 1 Diabetes Mellitus-Associated Genetic Variants Contribute to Overlapping Immune Regulatory Networks
Mark Vickers
Frontiers in Genetics, 2018
View PDFchevron_right
Heterogeneity of glycaemic phenotypes in type 1 diabetes
Gloria Aguayo
Diabetologia, 2024
View PDFchevron_right
Glycosylated haemoglobin and steady-state mean blood glucose concentration in type 1 (insulin-dependent) diabetes
Jørn Nerup
Diabetologia, 1982
View PDFchevron_right
Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study
Fabrizio Campi
Diabetes Care, 2020
View PDFchevron_right
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 277 Exploration of Conditions Affecting Cytokine Production in Experimental type 1 Diabetes Mellitus
Lina Thorvaldson
2007
View PDFchevron_right
Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetes
Luc Van Gaal
Diabetologia, 2006
View PDFchevron_right
Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes
Adolpho Milech
Diabetes Research and Clinical Practice, 2007
View PDFchevron_right
The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial)
Nanette Schloot
PLoS ONE, 2013
View PDFchevron_right